Epithelial CXCL1 tracks clinical remission in inflammatory bowel disease in a disease-specific manner

Sanmi E. Alake, Anil H. Kadam, Traci Jester, Craig L. Maynard, Babajide A. Ojo

Open source

DOI
10.3389/fimmu.2026.1904951
Published
2026-07-28
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1904951,
  title = {Epithelial CXCL1 tracks clinical remission in inflammatory bowel disease in a disease-specific manner},
  author = {Sanmi E. Alake and Anil H. Kadam and Traci Jester and Craig L. Maynard and Babajide A. Ojo},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1904951},
  url = {https://doi.org/10.3389/fimmu.2026.1904951}
}

RIS

TY  - JOUR
TI  - Epithelial CXCL1 tracks clinical remission in inflammatory bowel disease in a disease-specific manner
AU  - Sanmi E. Alake
AU  - Anil H. Kadam
AU  - Traci Jester
AU  - Craig L. Maynard
AU  - Babajide A. Ojo
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1904951
UR  - https://doi.org/10.3389/fimmu.2026.1904951
ER  - 

APA

Alake, S. E., Kadam, A. H., Jester, T., Maynard, C. L., & Ojo, B. A. (2026). Epithelial CXCL1 tracks clinical remission in inflammatory bowel disease in a disease-specific manner. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1904951

Source records